Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade.

André HennigsF RiedelF MarméP SinnK LindelA GondosK SmetanayM GolattaC SohnF SchuetzJ HeilA Schneeweiss

Published in: Breast cancer research and treatment (2016)

The results mirror the refined indication for chemotherapy in EBC and its preferred usage as NACT in Germany. The increase in pCR rate over time suggests improvement in outcome accomplished by a multidisciplinary decision-making process and stringent measures for quality control.

Keyphrases

quality control
end stage renal disease
early breast cancer
decision making
ejection fraction
chronic kidney disease
newly diagnosed
locally advanced
prognostic factors
peritoneal dialysis
radiation therapy
squamous cell carcinoma
patient reported outcomes
rectal cancer